(Q43548727)

English

Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids (English)

1 reference

Europe PubMed Central

24 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Grootendorst DC

1

1 reference

Europe PubMed Central

24 November 2017

Dahlén SE

2

1 reference

Europe PubMed Central

24 November 2017

Van Den Bos JW

3

1 reference

Europe PubMed Central

24 November 2017

Duiverman EJ

4

1 reference

Europe PubMed Central

24 November 2017

Veselic-Charvat M

5

1 reference

Europe PubMed Central

24 November 2017

Vrijlandt EJ

6

1 reference

Europe PubMed Central

24 November 2017

O'Sullivan S

7

1 reference

Europe PubMed Central

24 November 2017

Kumlin M

8

1 reference

Europe PubMed Central

24 November 2017

Sterk PJ

9

1 reference

Europe PubMed Central

24 November 2017

Roldaan AC

10

1 reference

Europe PubMed Central

24 November 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

24 November 2017

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

24 November 2017

31

1 reference

Europe PubMed Central

24 November 2017

3

1 reference

Europe PubMed Central

24 November 2017

400-408

1 reference

Europe PubMed Central

24 November 2017

Sensitization to dust mites as a dominant risk factor for asthma among adolescents living in central Virginia. Multiple regression analysis of a population-based study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Exposure to house dust mite allergens and the clinical activity of asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Allergen avoidance in the treatment of asthma and atopic disorders

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

House dust mite control measures in the management of asthma: meta-analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Asthma control versus asthma severity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Measuring quality of life in children with asthma.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Should study subjects see their previous responses: data from a randomized control trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Transcription factors and asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Inhaled glucocorticoids: new developments relevant to updating of the asthma management guidelines

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01022.X

21 January 2018

Identifiers

10.1046/J.1365-2222.2001.01022.X

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43548727&oldid=2098242879"